Hasil Pencarian - Rodrigo Refoios Camejo

  • Menampilkan 1 - 2 hasil dari 2
Perbaiki Hasil
  1. 1
    Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary

    Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling EraPlain-Language Summary oleh Borut Cizman, Helen T. Smith, Rodrigo Refoios Camejo, Linda Casillas, Harjeet Dhillon, Fan Mu, Eric Wu, Jipan Xie, Peter Zuckerman, Daniel Coyne

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.

    48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis. oleh Dipen A Patel, Sonya J Snedecor, Wing Yu Tang, Lavanya Sudharshan, Jessica W Lim, Robert Cuffe, Sonia Pulgar, Kim A Gilchrist, Rodrigo Refoios Camejo, Jennifer Stephens, Garrett Nichols

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: